Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
341
datasets available to search
ShareScore release 0.9.0
Dataset results
341 results for “pharmacists”
Data and code: Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non‐randomised pilot study
<p>This is a dataset and Stata analytical code relating to prescribing issues identified in the GPP pilot feasibility study. The paper reporting this study has been published as follows: </p> <p>Cardwell K, Smith SM, Clyne B on behalf of the General Practice Pharmacist (GPP) Study Group, et al. Evaluation of the General Practice Pharmacist (GPP) intervention to optimise prescribing in Irish primary care: a non-randomised pilot study. BMJ Open 2020;10:e035087. doi: 10.1136/bmjopen-2019-035087</p> <p>The abstract of the study is included below:</p> <p><strong>Objective:</strong> Limited evidence suggests integration of pharmacists into the general practice team could improve medicines management for patients, particularly those with multimorbidity and polypharmacy. This study aimed to develop and assess the feasibility of an intervention involving pharmacists, working within general practices, to optimise prescribing in Ireland.</p> <p><strong>Design:</strong> Non-randomised pilot study</p> <p><strong>Setting:</strong> Primary care in Ireland</p> <p><strong>Participants:</strong> Four general practices, purposively sampled and recruited to reflect a range of practice sizes and demographic profiles.</p> <p><strong>Intervention:</strong> A pharmacist joined the practice team for six months (10 hours/week) and undertook medication reviews (face-to-face or chart-based) for adult patients, provided prescribing advice, supported clinical audits, and facilitated practice-based education.</p> <p><strong>Outcome measures:</strong> Anonymised practice-level medication (e.g. medication changes) and cost data were collected. Patient-Reported Outcome Measure (PROM) data were collected on a subset of older adults (aged ≥65 years) with polypharmacy using patient questionnaires, before and six weeks after medication review by the pharmacist.</p> <p><strong>Results:</strong> Across four practices, 787 patients were identified as having 1,521 prescribing issues by the pharmacists. Issues relating to potentially inappropriate or high-risk prescribing were addressed most often by the prescriber (51.8%), compared to cost-related issues (7.5%). Medication changes made during the study equated to approximately €57,000 in cost savings assuming they persisted for 12 months. Ninety-six patients aged ≥65 years with polypharmacy were recruited from the four practices for PROM data collection and 64 (66.7%) were followed up. There were no changes in patients’ treatment burden or attitudes to deprescribing following medication review, and there were conflicting changes in patients' self-reported quality of life.</p> <p><strong>Conclusions:</strong> This non-randomised pilot study demonstrated that an intervention involving pharmacists, working within general practices is feasible to implement and has potential to improve prescribing quality. This study provides rationale to conduct a randomised controlled trial to evaluate the clinical and cost-effectiveness of this intervention.</p>
Nalox-Comm: Naloxone Communication Training for Pharmacists
ClinicalTrials.gov study NCT04677387. IPD Sharing: YES. Countries: 1. Publications: 13.
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists: A Stepped-Wedge Trial
ClinicalTrials.gov study NCT06547814. IPD Sharing: YES. Countries: 1. Publications: 5.
COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists
ClinicalTrials.gov study NCT05926544. IPD Sharing: YES. Countries: 1. Publications: 5.
Data from: Evaluation of a pharmacist-led actionable audit and feedback intervention for improving medication safety in primary care: an interrupted time series analysis
<p><strong>Background</strong>. We evaluated the impact of a pharmacist-led Safety Medication dASHboard (SMASH) intervention on medication safety in primary care.<br> <strong>Methods and findings</strong>. SMASH comprised: (1) training of clinical pharmacists to deliver the intervention; (2) a web-based dashboard providing actionable, patient-level feedback; and (3) pharmacists reviewing individual at-risk patients, and initiating remedial actions or advising general practitioners on doing so. It was implemented in forty-three general practices covering a population of 235,595 people in Salford (Greater Manchester), UK. All practices started receiving the intervention between 18 April 2016 and 26 September 2017. We used an interrupted time series analysis of rates of potentially hazardous prescribing and inadequate blood-test monitoring, comparing observed rates post-intervention to extrapolations from a 24-month pre-intervention trend. The number of people registered to participating practices and having one or more risk factors for being exposed to hazardous prescribing or inadequate blood-test monitoring at the start of the intervention was 47,413 (males: 23,073 [48.7%]; mean age: 60 [standard deviation: 21]). At baseline, 95% of practices had rates of potentially hazardous prescribing (composite of 10 indicators) between 0.88% and 6.19%. The prevalence of potentially hazardous prescribing reduced by 27.9% (95% confidence interval [CI], 20.3% to 36.8%) at 24 weeks and by 40.7% (95% CI, 29.1% to 54.2%) at twelve months after introduction of SMASH. The rate of inadequate blood-test monitoring (composite of 2 indicators) reduced by 22.0% (95% CI, 0.2% to 50.7%) at 24 weeks and by 23.5% (95% CI, -4.5% to 61.6%) at 12 months. After 12 months, 95% of practices had rates of potentially hazardous prescribing between 0.74% and 3.02%. We did not randomise practices but enrolled them in a naturalistic fashion. All our measurements were based on routinely kept electronic health records.<br> <strong>Conclusions</strong>. The SMASH intervention was associated with reduced rates of potentially hazardous prescribing and inadequate blood-test monitoring in general practices. This reduction was sustained over 12 months after start of the intervention for prescribing but not for monitoring of medication. There was a marked reduction in the variation in rates of high-risk prescribing between practices.</p>
CONSORT flow diagram for The assessment of educational and supportive care to the infertile females undergoes In Vitro Fertilization procedure by clinical pharmacist: a randomized clinical trial
<p><strong>The assessment of educational and supportive care to the infertile females undergoes In Vitro Fertilization procedure by </strong>a <strong>clinical pharmacist: a randomized clinical trial</strong>.</p>
Community Pharmacists Vaccinate Against Cancer
ClinicalTrials.gov study NCT04072159. IPD Sharing: NO. Countries: 1. Publications: 1.
Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
ClinicalTrials.gov study NCT03239665. IPD Sharing: NO. Countries: 1. Publications: 30.
Solving Stigma Through POV Simulation: Enhancing Pharmacist Empathy-based Practices With Sickle Cell Disease Patients
ClinicalTrials.gov study NCT07217548. IPD Sharing: NO. Countries: 1. Publications: 4.
Pharmacist Provision of Medication Abortion
ClinicalTrials.gov study NCT04956731. IPD Sharing: NO. Countries: 1. Publications: 1.
Pharmacist-led Group Medical Visits to Help With Diabetes Management
ClinicalTrials.gov study NCT00554671. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
ClinicalTrials.gov study NCT03986931. IPD Sharing: NO. Countries: 1. Publications: 2.
Association Between Geriatric Frailty and Medication Related Problems in the Emergency Department to Help Clinical Pharmacists Prioritise Patients
ClinicalTrials.gov study NCT07282379. IPD Sharing: YES. Countries: 1. Publications: 6.
Effect of a trAnSitional Pharmacist Intervention in geRiatric Inpatients on Hospitals Visits After dischargE
ClinicalTrials.gov study NCT04617340. IPD Sharing: NO. Countries: 1. Publications: 3.
The Impact of Clinical Pharmacist in the Identification and Management of Treatment Related Problems in the Surgery Ward
ClinicalTrials.gov study NCT04941820. IPD Sharing: NO. Countries: 1. Publications: 4.
Pharmacist Intervention to Reduce Post-Hospitalization Utilization
ClinicalTrials.gov study NCT04071951. IPD Sharing: NO. Countries: 1. Publications: 2.
Improving Transplant Medication Safety Through A Technology and Pharmacist Intervention
ClinicalTrials.gov study NCT03860818. IPD Sharing: NO. Countries: 1. Publications: 3.
Assessing the Effectiveness of a Pharmacist-delivered Smoking Cessation Program in the State of Qatar
ClinicalTrials.gov study NCT02123329. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Before-after Comparison of Pharmacist Drug Therapy Management in Pediatric Hypertension
ClinicalTrials.gov study NCT04098978. IPD Sharing: YES. Countries: 1. Publications: 13.
A Trial on the Role of Community Pharmacist in Improving Adherence and Clinical Outcomes in Post-Infarction
ClinicalTrials.gov study NCT03621111. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.